Publication

Byline

Meet Subhadeep Ghosh - Ex-Assam cricketer set to take over as India's fielding coach in Gautam Gambhir's backroom staff

New Delhi, July 28 -- The BCCI bid goodbye to assistant coach Ryan ten Doeschate and fielding coach T Dilip on Tuesday, after Indian cricket board decided not to renew the contracts of the two individ... और पढ़ें


Taste of their own medicine: How Gen Z reels are catching up to BJP

Hyderabad, July 28 -- During the height of the Cockroach Janta Party (CJP)-led students' protests at Jantar Mantar in Delhi, Gen Z protesters flooded social media with creative memes, reels, and poste... और पढ़ें


Over 48 Lakh Households Benefit Under PM Surya Ghar: Muft Bijli Yojana Since February 2024

The PM Surya Ghar, July 28 -- Muft Bijli Yojana (PMSG: MBY) is a demand-driven scheme wherein all residential consumers in the country including the rural households, having a grid-connected electrici... और पढ़ें


India Rejects Claims Linking Illegal Migrant Returns to Nirav Modi Extradition Case

Goa, July 28 -- The Ministry of External Affairs (MEA) on Tuesday rejected claims that India's cooperation in taking back illegal migrants from the United Kingdom was linked to the extradition of fugi... और पढ़ें


IDFC First Bank shares extend post-Q1FY27 results rally. Will it climb to a new 52-week high?

New Delhi, July 28 -- IDFC First Bank shares extended their post-earnings rally on Tuesday, 29 July, after the private lender reported its highest-ever quarterly profit for the first quarter of FY27. ... और पढ़ें


Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, July 28 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... और पढ़ें


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, July 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... और पढ़ें


Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, July 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... और पढ़ें


Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, July 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... और पढ़ें


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, July 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... और पढ़ें